12-108591896-T-A
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_181724.3(TMEM119):c.488A>T(p.Glu163Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000192 in 1,612,180 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_181724.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM119 | NM_181724.3 | c.488A>T | p.Glu163Val | missense_variant | 2/2 | ENST00000392806.4 | NP_859075.2 | |
TMEM119 | XM_011538271.3 | c.488A>T | p.Glu163Val | missense_variant | 3/3 | XP_011536573.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM119 | ENST00000392806.4 | c.488A>T | p.Glu163Val | missense_variant | 2/2 | 1 | NM_181724.3 | ENSP00000376553 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152076Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000244 AC: 6AN: 245814Hom.: 0 AF XY: 0.0000373 AC XY: 5AN XY: 133928
GnomAD4 exome AF: 0.0000199 AC: 29AN: 1460104Hom.: 0 Cov.: 30 AF XY: 0.0000234 AC XY: 17AN XY: 726282
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152076Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74288
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 26, 2022 | The c.488A>T (p.E163V) alteration is located in exon 2 (coding exon 1) of the TMEM119 gene. This alteration results from a A to T substitution at nucleotide position 488, causing the glutamic acid (E) at amino acid position 163 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at